Literature DB >> 22767412

Ablation for atrial fibrillation: CT overlay or standard electroanatomical mapping?

E E van der Wall1.   

Abstract

Entities:  

Year:  2012        PMID: 22767412      PMCID: PMC3402569          DOI: 10.1007/s12471-012-0301-y

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


× No keyword cloud information.
The outcome of catheter ablation procedures for cardiac arrhythmias depends on the ability to evaluate the underlying mechanism and to depict target sites for ablation [1-10]. Image fusion and integration have become routine procedures in the diagnosis and treatment of various cardiovascular disorders [11-16]. Fusion of different imaging modalities within one system may improve electroanatomical modelling and facilitate ablation procedures. Nowadays, three-dimensional (3D) navigation systems are widely used for pulmonary vein antrum isolation [17-24]. However, use of electroanatomical mapping systems may increase procedural duration and overheads, and may limit the choice of ablation catheters. As an alternative to circumvent left atrial mapping, 3D computed tomography (CT) reconstructions of the left atrium can be superimposed directly (CT overlay) on the fluoroscopy image to guide ablation catheters and to mark ablation sites. In the present issue of the Netherlands Heart Journal, Van der Voort et al. [25] describe their initial experience with 3D overlay for ablation of atrial fibrillation. They evaluated the feasibility of the CT overlay technique for pulmonary vein antrum isolation and its equivalence to established electroanatomical mapping. To this purpose, the authors performed circumferential pulmonary vein ablation in 71 patients with atrial fibrillation. They performed 3D reconstructions of the left atrium, which were derived from contrast cardiac CT and circumferential pulmonary vein isolation. CT was initially performed using a 64-slice CT scanner, and later a 256-slice CT scanner, with 85 ml of intravenous contrast. Initial follow-up was scheduled at 2 to 3 months after each ablation, at 6 months, and for every 6 months subsequently. In subsequent ablation procedures, veins were re-isolated, and defragmentation or linear lesions were performed if necessary. Outcome was based on symptoms and subsequent electrocardiographic confirmation of atrial fibrillation or tachycardia. The authors found that adequate 3D reconstructions were formed and registered to fluoroscopy in all patients. All veins, except 2 in one single patient, could be isolated, resulting in freedom of atrial fibrillation in 45 patients (63 %). In 19 patients a second procedure was performed, in which 2.7 ± 1.1 pulmonary veins per patient were re-isolated; in 3 patients a third procedure was performed. After follow-up of 15 ± 8 months, 51 (91 %) patients with paroxysmal and 10 (67 %) with persistent atrial fibrillation were free of arrhythmia. The authors concluded that the results of 3D overlay for circumferential pulmonary vein isolation are good. The 3D overlay technique is comparable with other techniques, both for paroxysmal and persistent atrial fibrillation. In addition, it was demonstrated that the need for subsequent ablations remains high due to a high incidence of recovery of conduction from the pulmonary veins, but the recovery rate was similar to standard techniques. Therefore, the outcomes of the 3D overlay technique generally appear to be equivalent to other mapping techniques. The authors further claim that, based on other studies, their method of image integration is feasible in terms of handling radiation exposure and having lower costs. However, nowadays both patients and operators are entitled to know the exact radiation dose they receive. Therefore, precise data regarding the total radiation burden should be provided. Along those lines, the potential cost reduction associated with the 3D overlay technique should be given in more accurate terms, certainly when the 3D technique is said to be equivalent to other mapping techniques. In a previous study by the same group [26], the authors had already successfully evaluated 68 patients with symptomatic atrial fibrillation refractory to medical therapy who were randomly assigned to CT overlay (group 1, n = 38) or to a new image integration module called CartoMerge (group 2, n = 30). In that study they found that CT overlay for pulmonary vein isolation is feasible and may, in comparison with conventional left atrial navigation systems, shorten procedural time without an increase in radiation burden. In our centre, Tops et al. [27] had already shown in 16 patients with atrial fibrillation that CT images can be fused with the three-dimensional electroanatomical mapping system in an accurate manner. It was concluded that anatomy-based catheter ablation procedures for atrial arrhythmias may be facilitated by integration of different imaging modalities. Also, Kardos et al. [28] showed that highly accurate CT imaging and the electroanatomical map fusion can be obtained by the Carto 3D electroanatomical mapping system using the coronary sinus as the key anatomical structure for registration. Using this technique the mapping time of the left atrium can be reduced. Finlay et al. [29], however, recently found in the CAVERN trial that CartoMerge appears to be faster and uses less fluoroscopy to achieve registration than 3D image integration using NavX Fusion, but overall procedural times and clinical outcomes were similar. To summarise, although the current study provides promising data, a prospective, randomised study should be conducted–as the authors also indicated–to adequately compare the current CT overlay technique with standard electroanatomical mapping systems in patients eligible for ablation of atrial fibrillation.
  29 in total

1.  Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.

Authors:  J L M Hendriks; R Nieuwlaat; H J M Vrijhoef; R de Wit; H J G M Crijns; R G Tieleman
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

2.  Radiofrequency catheter ablation of paroxysmal atrial fibrillation; guidance by intracardiac echocardiography and integration with other imaging techniques.

Authors:  M R M Jongbloed; J J Bax; N M S de Groot; M S Dirksen; H J Lamb; A de Roos; E E van der Wall; M J Schalij
Journal:  Eur J Echocardiogr       Date:  2003-03

3.  New guidelines for the management of atrial fibrillation: what's new?

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2010-11       Impact factor: 2.380

4.  The burden of atrial fibrillation in the Netherlands.

Authors:  H E Heemstra; R Nieuwlaat; M Meijboom; H J Crijns
Journal:  Neth Heart J       Date:  2011-09       Impact factor: 2.380

5.  Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score.

Authors:  Maureen M Henneman; Joanne D Schuijf; Gabija Pundziute; Jacob M van Werkhoven; Ernst E van der Wall; J Wouter Jukema; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

6.  MR imaging of acute myocardial infarction: value of Gd-DTPA.

Authors:  A de Roos; J Doornbos; E E van der Wall; A E van Voorthuisen
Journal:  AJR Am J Roentgenol       Date:  1988-03       Impact factor: 3.959

Review 7.  Multi-modality imaging to assess left atrial size, anatomy and function.

Authors:  Laurens F Tops; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  Heart       Date:  2007-11       Impact factor: 5.994

8.  Atrial fibrillation with a giant left atrial appendage can be successfully treated with pulmonary vein antrum isolation.

Authors:  I E Hof; T X Wildbergh; V J van Driel; F H Wittkampf; M J Cramer; M Meine; R N Hauer; P Loh
Journal:  Neth Heart J       Date:  2012-04       Impact factor: 2.380

9.  Cardiac magnetic resonance imaging in stable ischaemic heart disease.

Authors:  S W Kirschbaum; P J de Feyter; R-J M van Geuns
Journal:  Neth Heart J       Date:  2011-05       Impact factor: 2.380

10.  Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability.

Authors:  M A G M Olimulder; M A Galjee; J van Es; L J Wagenaar; C von Birgelen
Journal:  Neth Heart J       Date:  2011-05       Impact factor: 2.380

View more
  1 in total

1.  Crown years for non-invasive cardiovascular imaging (Part IV): 30 years of cardiac computed tomography.

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2013-07       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.